AMLX

AMLX Total Non-Current Liabilities

$4.25MQuarterly · USD

Period ending:

AMLX FY Total Non-Current LiabilitiesUSD
AMLX FY Total Non-Current Liabilities2019-12-31: $24.05M2020-12-31: $73.50M2021-12-31: $239.39M2022-12-31: $4.24M2023-12-31: $1.98M2024-12-31: $463.00K2025-12-31: $4.70M$239.39M$0.00
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AMLX total non-current liabilities history

Long-term obligations due beyond one year. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Amylyx Pharmaceuticals Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)
4,698,000
463,000
1,980,000
4,237,000
239,386,000
73,503,000
24,048,000

Compare total non-current liabilities

All AMLX financial metrics · AMLX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.